SeaSun Biomaterials (CEO Hee-Kyung Park), a company that develops diagnostic reagents for in vitro diagnostics, is the AQ-TOP COVID-19 Rapid Detection Kit, a diagnostic kit that can diagnose COVID-19 infection within 15 minutes.) Has been developed.

The diagnostic kit developed by this company applied rapid gene amplification technology. Although it focused on quickly diagnosing the presence of COVID-19 infection, the diagnosis accuracy is more than 98%, similar to that of real-time gene amplification (RT-PCR).

Genes amplified using artificial DNA (PNA) were detected with high sensitivity, and the incidence of false negatives and false positives was reduced to increase accuracy. In order to be used by general hospitals and public health centers, and to increase portability, it has been miniaturized to one quarter of the size of existing equipment.

CEO Park Hee-kyung said, “We focused on improving the accuracy and usability of the test.” “As preparations for overseas expansion such as obtaining European CE certification and overseas export negotiations are proceeding smoothly, we plan to start exporting products in earnest when clinical verification is completed.” said.